Simulations Plus (NASDAQ:SLP) Given “Outperform” Rating at William Blair

William Blair reissued their outperform rating on shares of Simulations Plus (NASDAQ:SLP) in a research report released on Wednesday morning,RTT News reports.

Other research analysts also recently issued reports about the stock. Stephens started coverage on shares of Simulations Plus in a research report on Friday, November 15th. They issued an “overweight” rating and a $39.00 target price on the stock. BTIG Research dropped their target price on shares of Simulations Plus from $60.00 to $50.00 and set a “buy” rating on the stock in a research report on Thursday, October 24th. Finally, StockNews.com downgraded shares of Simulations Plus from a “hold” rating to a “sell” rating in a research report on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Simulations Plus currently has an average rating of “Moderate Buy” and an average price target of $49.00.

Simulations Plus Trading Down 7.2 %

Shares of NASDAQ:SLP opened at $28.21 on Wednesday. Simulations Plus has a 52 week low of $24.00 and a 52 week high of $51.22. The company’s 50 day moving average is $29.79 and its two-hundred day moving average is $34.00. The company has a market cap of $566.60 million, a PE ratio of 57.57 and a beta of 0.80.

Simulations Plus (NASDAQ:SLP) last announced its quarterly earnings data on Wednesday, October 23rd. The technology company reported $0.06 EPS for the quarter, beating analysts’ consensus estimates of $0.04 by $0.02. The company had revenue of $18.70 million for the quarter, compared to the consensus estimate of $19.73 million. Simulations Plus had a net margin of 14.15% and a return on equity of 6.16%. The company’s quarterly revenue was up 19.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.18 EPS. As a group, equities research analysts expect that Simulations Plus will post 1.1 EPS for the current year.

Insider Buying and Selling

In other news, Director Walter S. Woltosz sold 20,000 shares of the firm’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $31.76, for a total value of $635,200.00. Following the completion of the sale, the director now owns 3,442,584 shares in the company, valued at approximately $109,336,467.84. This trade represents a 0.58 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 19.40% of the stock is owned by company insiders.

Institutional Trading of Simulations Plus

Several hedge funds have recently made changes to their positions in the company. Tributary Capital Management LLC lifted its stake in shares of Simulations Plus by 54.7% in the third quarter. Tributary Capital Management LLC now owns 325,567 shares of the technology company’s stock valued at $10,425,000 after purchasing an additional 115,122 shares during the period. Royce & Associates LP lifted its stake in shares of Simulations Plus by 28.8% in the third quarter. Royce & Associates LP now owns 237,416 shares of the technology company’s stock valued at $7,602,000 after purchasing an additional 53,092 shares during the period. Dimensional Fund Advisors LP lifted its stake in shares of Simulations Plus by 10.1% in the second quarter. Dimensional Fund Advisors LP now owns 414,005 shares of the technology company’s stock valued at $20,128,000 after purchasing an additional 37,992 shares during the period. Congress Asset Management Co. lifted its stake in shares of Simulations Plus by 22.5% in the third quarter. Congress Asset Management Co. now owns 206,542 shares of the technology company’s stock valued at $6,613,000 after purchasing an additional 37,914 shares during the period. Finally, BNP Paribas Financial Markets lifted its stake in shares of Simulations Plus by 402.9% in the third quarter. BNP Paribas Financial Markets now owns 39,944 shares of the technology company’s stock valued at $1,279,000 after purchasing an additional 32,002 shares during the period. Institutional investors and hedge funds own 78.08% of the company’s stock.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.